Related Experiment Video
Updated: May 16, 2026
15:18
Near Infrared Optical Projection Tomography for Assessments of β-cell Mass Distribution in Diabetes Research
Published on: January 12, 2013
18F-DOPA positron emission tomography/computed tomography application in congenital hyperinsulinism
Jigang Yang1, Leilei Yuan, Jacqui K Meeks
1Department of Nuclear Medicine, Beijing Friendship Hospital of Capital Medical University, Beijing 100050, China.
Journal of Pediatric Endocrinology & Metabolism : JPEM
|November 20, 2012
Summary
Congenital hyperinsulinism (CHI) in infants causes hypoglycemia due to excess insulin. Fluorine-18-DOPA Positron Emission Tomography/Computed Tomography (18F-DOPA PET/CT) helps differentiate focal from diffuse lesions, guiding surgical treatment.
Area of Science:
- Pediatric Endocrinology
- Nuclear Medicine Imaging
Background:
- Congenital hyperinsulinism (CHI) in infants presents as inappropriate insulin secretion, leading to persistent hypoglycemia and potential neurological damage.
- Histologic subtypes, diffuse and focal CHI, necessitate distinct surgical approaches, making accurate differentiation crucial.
- Distinguishing between focal and diffuse CHI lesions poses a significant diagnostic challenge.
Purpose of the Study:
- To review the application of 18F-DOPA PET/CT in diagnosing congenital hyperinsulinism.
- To enhance awareness and recognition of 18F-DOPA PET/CT's utility in CHI diagnosis.
Main Methods:
- Review of existing literature on 18F-DOPA PET/CT in congenital hyperinsulinism.
- Explanation of the principle: 18F-DOPA uptake reflects metabolic activity in hyperinsulinemic pancreatic tissue.
Main Results:
- 18F-DOPA PET/CT enables functional mapping of hyperinsulinism by highlighting areas of increased dihydroxyphenylalanine (DOPA) utilization.
- This technique aids in differentiating focal from diffuse CHI, which is critical for surgical planning.
Conclusions:
- 18F-DOPA PET/CT is a valuable tool for the diagnosis and management of congenital hyperinsulinism.
- Improved recognition of 18F-DOPA PET/CT can lead to more precise surgical strategies and better patient outcomes in CHI.
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)
Related Concept Videos
01:29Positron Emission Tomography
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
01:25Imaging Studies II: Positron Emission Tomography and Scintigraphy
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET